Contributors

Professor Sean Hood

Professor Sean Hood’s primary research focus is clinical psychopharmacology of anxiety disorders, which involves the investigation of medication effects and mechanisms in populations with clinical anxiety disorders. He did his undergraduate medical degree at the University of Western Australia before completing formal postgraduate training in psychiatry in Perth, and Bristol, UK. He then returned to Perth and set up a clinical psychopharmacology laboratory as a clinical academic with UWA’s Division of Psychiatry.  

Professor Hood is past Chair of the Australian Pristiq Advisory Board, and member of the Australian Cymbalta, Brintellix, Spravato and Latuda Advisory Boards. He is the Australian Board member for the European Masters in Affective Neuroscience degree and summer course on Mood, Aggression & Attraction, run jointly by the Universities of Florence and Maastricht. He is also a Director of the Young Lives Matter Foundation, a large-scale interdisciplinary research initiative at UWA focused on combating the issue of youth suicide. 

He is a psychiatrist in public and private practice, and his public practice includes Headship of the SCGH MHU Treatment Resistant Anxiety and Mood Disorder Unit (TRAMD). Professor Hood maintains an active engagement in medical student education, chairing the Systems Committee of the new UWA Doctor of Medicine program prior to implementation in 2014.